Back to Search
Start Over
Tiotropium Respimat increases the risk of mortality.
- Source :
-
Thorax [Thorax] 2013 Jan; Vol. 68 (1), pp. 5-7. - Publication Year :
- 2013
- Subjects :
- Administration, Inhalation
Bronchodilator Agents therapeutic use
Evidence-Based Medicine
Female
Humans
Male
Myocardial Infarction chemically induced
Myocardial Infarction mortality
Randomized Controlled Trials as Topic
Risk Assessment
Scopolamine Derivatives therapeutic use
Stroke chemically induced
Stroke mortality
Survival Analysis
Tiotropium Bromide
United States
United States Food and Drug Administration
Bronchodilator Agents adverse effects
Cause of Death
Pulmonary Disease, Chronic Obstructive drug therapy
Pulmonary Disease, Chronic Obstructive mortality
Scopolamine Derivatives adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1468-3296
- Volume :
- 68
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Thorax
- Publication Type :
- Editorial & Opinion
- Accession number :
- 23229813
- Full Text :
- https://doi.org/10.1136/thoraxjnl-2012-202482